Product Pipeline

(As of September 2025)

Development Pipelines

Product code Target Indication Dosage Form Development region Current Phase
M6050C Acne vulgaris Topical JP Approved
M5250E Pruritus with atopic dermatitis (infant) Injection JP PIII
M6100 Atopic dermatitis Topical JP PIII
M6050F Axillary osmidrosis Topical JP PII
M6120 Chronic spontaneous urticaria Oral JP PII